Replagal

Showing 3 posts of 3 posts found.

Shire picture

Robust sales for Shire

February 13, 2012
Sales and Marketing Replagal, Shire, Vpriv, Vyvanse

A rise in the use of attention deficit and hyperactivity disorder drugs has helped push Shire’s turnover past $4 billion …

Shire gets green light for second Replagal facility

June 28, 2011
Manufacturing and Production Replagal, Shire, Vpriv, pharma manufacturing news

The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …

Shire says new plant will add to Replagal, Vpriv capacity

January 17, 2011
Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv

UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …

The Gateway to Local Adoption Series

Latest content